Article Information
History
- May 30, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Joseph Park1,2,3,
- Elizabeth A Packard2,
- Michael G Levin2,
- Renae L Judy4,
- Regeneron Genetics Center5,
- Scott M Damrauer4,
- Sharlene M Day2,
- Marylyn D Ritchie1,3 and
- Daniel J Rader1,2,6,*
- 1Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
- 2Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
- 3Institute for Biomedical Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
- 4Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
- 5Regeneron Genetics Center, Regeneron Pharmaceuticals, Tarrytown, NY, 10591, USA
- 6Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
- ↵*To whom correspondence should be addressed: Daniel J. Rader, MD, rader{at}pennmedicine.upenn.edu, Perelman School of Medicine at the University of Pennsylvania and Children’s Hospital of Philadelphia, 11-125 Smilow Center for Translational Research, 3400 Civic Center Blvd, Philadelphia, PA 19104-5158, Tel: 215-573-4176
Posted May 30, 2021.
A genome-first approach to rare variants in hypertrophic cardiomyopathy genes MYBPC3 and MYH7 in a medical biobank
